Comparative drug screening in NUT midline carcinoma

BACKGROUND: The NUT midline carcinoma (NMC) is a rare but fatal cancer for which systematic testing of therapy options has never been performed. METHODS: On the basis of disease biology, we compared the efficacy of the CDK9 inhibitor flavopiridol (FP) with a panel of anticancer agents in NMC cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Beesley, A H, Stirnweiss, A, Ferrari, E, Endersby, R, Howlett, M, Failes, T W, Arndt, G M, Charles, A K, Cole, C H, Kees, U R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950881/
https://www.ncbi.nlm.nih.gov/pubmed/24518598
http://dx.doi.org/10.1038/bjc.2014.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950881/
https://www.ncbi.nlm.nih.gov/pubmed/24518598
http://dx.doi.org/10.1038/bjc.2014.54

Ejemplares similares